Search research articles
Contact Us
Filters
Showing results (171-180 of 216) with videos related to
Page
of 22
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 29, 2022
A Visual Interpretation Algorithm for Assessing Brain Tauopathy with <sup>18</sup>F-MK-6240 PET
John P Seibyl, Jonathan M DuBois, Annie Racine, et al.
Molecular Imaging
|
February 1, 2023
Evaluation of Intraperitoneal [<sup>18</sup>F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity
Els F Halff, Sridhar Natesan, David R Bonsall, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2018
Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study
Ríona Mc Ardle, Rosie Morris, Aodhán Hickey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 22, 2021
Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [<sup>11</sup>C]PHNO PET
Eugenii A Rabiner, Tolga Uz, Ayla Mansur, et al.
Imaging Neuroscience (Cambridge, Mass.)
|
February 24, 2025
The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study
Ekaterina Shatalina, Ellis Chika Onwordi, Thomas Whitehurst, et al.
Molecular Psychiatry
|
June 27, 2018
Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals
Samuel Turton, James Fm Myers, Inge Mick, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 21, 2013
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography
Robert A Comley, Cristian A Salinas, Mark Slifstein, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 17, 2014
Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET
Khanum Ridler, Roger N Gunn, Graham E Searle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 12, 2014
Phosphodiesterase 10A PET radioligand development program: from pig to human
Christophe Plisson, David Weinzimmer, Steen Jakobsen, et al.
JAMA Psychiatry
|
December 10, 2025
Role of Serotonin in the Neurobiology of Schizophrenia and Association With Negative Symptoms
Martin Osugo, Thomas Whitehurst, David Erritzoe, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 216) with videos related to
Sort By:
Page
of 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 29, 2022
A Visual Interpretation Algorithm for Assessing Brain Tauopathy with <sup>18</sup>F-MK-6240 PET
John P Seibyl, Jonathan M DuBois, Annie Racine, et al.
Molecular Imaging
|
February 1, 2023
Evaluation of Intraperitoneal [<sup>18</sup>F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity
Els F Halff, Sridhar Natesan, David R Bonsall, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2018
Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study
Ríona Mc Ardle, Rosie Morris, Aodhán Hickey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 22, 2021
Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [<sup>11</sup>C]PHNO PET
Eugenii A Rabiner, Tolga Uz, Ayla Mansur, et al.
Imaging Neuroscience (Cambridge, Mass.)
|
February 24, 2025
The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study
Ekaterina Shatalina, Ellis Chika Onwordi, Thomas Whitehurst, et al.
Molecular Psychiatry
|
June 27, 2018
Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals
Samuel Turton, James Fm Myers, Inge Mick, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 21, 2013
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography
Robert A Comley, Cristian A Salinas, Mark Slifstein, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 17, 2014
Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET
Khanum Ridler, Roger N Gunn, Graham E Searle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 12, 2014
Phosphodiesterase 10A PET radioligand development program: from pig to human
Christophe Plisson, David Weinzimmer, Steen Jakobsen, et al.
JAMA Psychiatry
|
December 10, 2025
Role of Serotonin in the Neurobiology of Schizophrenia and Association With Negative Symptoms
Martin Osugo, Thomas Whitehurst, David Erritzoe, et al.
Page
of 22